Iktos is a French start-up company that develops a truly innovative and disruptive artificial intelligence technology for ligand-based de novo drug design, focusing on MPO (multi-parametric optimization). Our innovative algorithm is based on the state of the art deep learning models, called generative models, and enables to the design of new, druggable, and synthesizable molecules under the constraint of a given blueprint, with unprecedented speed and performance.
Total Funding: N/A
Funding Stage: Funded
Business Stage: Scaling Up
Market: B2B
Company Size: 1 to 25
Founded: 2016
For AI/ML Startup Founders
Get introduced to VC/PE/CVC investors
For Investors at VC/PE firms
Get introduced to AI/ML Startup founders or founders at Iktos
